Inspire Investing LLC Sells 5,790 Shares of Omega Healthcare Investors, Inc. $OHI

Inspire Investing LLC lowered its holdings in shares of Omega Healthcare Investors, Inc. (NYSE:OHI) by 10.0% during the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 52,110 shares of the real estate investment trust’s stock after selling 5,790 shares during the period. Inspire Investing LLC’s holdings in Omega Healthcare Investors were worth $1,910,000 at the end of the most recent reporting period.

Other hedge funds have also bought and sold shares of the company. NBC Securities Inc. bought a new stake in Omega Healthcare Investors during the first quarter worth about $29,000. MassMutual Private Wealth & Trust FSB boosted its stake in Omega Healthcare Investors by 562.3% during the second quarter. MassMutual Private Wealth & Trust FSB now owns 1,828 shares of the real estate investment trust’s stock worth $67,000 after acquiring an additional 1,552 shares in the last quarter. Register Financial Advisors LLC bought a new stake in Omega Healthcare Investors during the second quarter worth about $73,000. UMB Bank n.a. boosted its stake in Omega Healthcare Investors by 94.9% during the first quarter. UMB Bank n.a. now owns 2,175 shares of the real estate investment trust’s stock worth $83,000 after acquiring an additional 1,059 shares in the last quarter. Finally, Meeder Asset Management Inc. boosted its stake in Omega Healthcare Investors by 1,581.3% during the first quarter. Meeder Asset Management Inc. now owns 2,522 shares of the real estate investment trust’s stock worth $96,000 after acquiring an additional 2,372 shares in the last quarter. Institutional investors own 65.25% of the company’s stock.

Omega Healthcare Investors Stock Down 0.9%

OHI opened at $39.83 on Friday. The company has a quick ratio of 7.10, a current ratio of 7.10 and a debt-to-equity ratio of 0.96. The firm has a 50 day moving average price of $41.57 and a 200-day moving average price of $38.81. Omega Healthcare Investors, Inc. has a twelve month low of $35.04 and a twelve month high of $44.42. The stock has a market capitalization of $11.75 billion, a price-to-earnings ratio of 24.59, a PEG ratio of 1.86 and a beta of 0.70.

Omega Healthcare Investors (NYSE:OHI) last released its quarterly earnings data on Thursday, July 31st. The real estate investment trust reported $0.77 earnings per share for the quarter, beating the consensus estimate of $0.45 by $0.32. Omega Healthcare Investors had a net margin of 42.23% and a return on equity of 9.78%. The firm had revenue of $235.60 million during the quarter, compared to analysts’ expectations of $248.49 million. During the same period in the previous year, the company earned $0.71 earnings per share. The firm’s quarterly revenue was up 11.8% on a year-over-year basis. Omega Healthcare Investors has set its FY 2025 guidance at 3.040-3.070 EPS. Equities research analysts forecast that Omega Healthcare Investors, Inc. will post 2.86 earnings per share for the current year.

Omega Healthcare Investors Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Friday, August 15th. Stockholders of record on Monday, August 4th were issued a dividend of $0.67 per share. This represents a $2.68 annualized dividend and a dividend yield of 6.7%. The ex-dividend date of this dividend was Monday, August 4th. Omega Healthcare Investors’s payout ratio is presently 165.43%.

Analysts Set New Price Targets

Several research analysts have issued reports on OHI shares. Raymond James Financial reaffirmed an “outperform” rating on shares of Omega Healthcare Investors in a report on Tuesday, September 2nd. Cantor Fitzgerald started coverage on shares of Omega Healthcare Investors in a report on Wednesday, October 1st. They issued an “overweight” rating and a $50.00 target price for the company. Truist Financial lifted their target price on shares of Omega Healthcare Investors from $39.00 to $44.00 and gave the stock a “hold” rating in a report on Wednesday, September 3rd. Wells Fargo & Company lifted their target price on shares of Omega Healthcare Investors from $41.00 to $44.00 and gave the stock an “overweight” rating in a report on Wednesday, August 27th. Finally, Mizuho lifted their target price on shares of Omega Healthcare Investors from $37.00 to $40.00 and gave the stock a “neutral” rating in a report on Thursday, September 11th. Seven research analysts have rated the stock with a Buy rating and five have issued a Hold rating to the company. According to MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $44.44.

Insider Buying and Selling

In other Omega Healthcare Investors news, Director Lisa Egbuonu-Davis sold 2,500 shares of the company’s stock in a transaction that occurred on Friday, August 8th. The shares were sold at an average price of $40.16, for a total transaction of $100,400.00. Following the completion of the sale, the director directly owned 18,654 shares of the company’s stock, valued at approximately $749,144.64. This represents a 11.82% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Corporate insiders own 1.50% of the company’s stock.

About Omega Healthcare Investors

Omega Healthcare Investors, Inc engages in the provision of financing and capital to the long-term healthcare industry with a particular focus on skilled nursing facilities, assisted living facilities, independent living facilities, rehabilitation and acute care facilities, and medical office buildings.